Heterogeneity in disease activity, frequency of treatments, and visual outcomes among patients with retinal vein occlusion: relationship between injection need and vision with as-needed ranibizumab.
Robert B BhisitkulPeter A CampochiaroSteven BlotnerCarlos Quezada-RuizMimi LiuZdenka HaskovaPublished in: The British journal of ophthalmology (2024)
The BRVO/CRVO population is heterogenous with a varied response to ranibizumab treatment.
Keyphrases
- disease activity
- diabetic retinopathy
- systemic lupus erythematosus
- rheumatoid arthritis
- rheumatoid arthritis patients
- ankylosing spondylitis
- age related macular degeneration
- optical coherence tomography
- juvenile idiopathic arthritis
- single cell
- ultrasound guided
- combination therapy
- skeletal muscle
- smoking cessation